As the Center for Medicare and Medicaid Innovation moves forward with additional drug-focused models, our Part D Senior ...
State-of-the-art AI programs can support the development of drugs by predicting how proteins interact with small molecules. However, a new study by researchers at the University of Basel published in ...
An international team involving the Institute of Chemical Research, a joint center of the University of Seville and the ...
Adobe’s agentic AI tools are turbocharging brand creativity, leading to fast, collaborative, and deeply human campaigns.
Philly police and federal authorities used wiretaps, cameras, and confidential informants to target dealers on Weymouth ...
Learn about the advancements showcased at ELRIG’s Drug Discovery 2025. Discover practical solutions for modern drug research.
For rare diseases, AI-driven repurposing fills a critical gap. With more than 7000 rare diseases and only a small percentage ...
Genesis’ proprietary foundation model – Pearl – outperforms frontier models, including AlphaFold 3, on key benchmarks that predict utility in real-world drug discovery Pearl’s performance improved ...
“The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch. Synthesis is ...
In the decades following deinstitutionalization, the U.S. has yet to find an effective model of a comprehensive behavioral ...
The UK drug development process is evolving. Find out how government efforts are reducing clinical trial timelines for new ...
The Allen Institute for AI (Ai2) unveiled Olmo 3, a new generation of open language models that it says outperforms rivals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback